De novo design of allosterically regulated proteins to study intramolecular signal transduction
About This Grant
This proposal aims to design proteins from scratch that can undergo intramolecular allosteric regulation, a process crucial to central metabolism, genetic regulatory networks, and biological sensing. If we truly understand the molecular biomechanics behind allosteric regulation, then we should be able to design proteins that use remote binding of a ligand to control small molecule release. Recent work has demonstrated the possibility of changing remote protein conformation through fold switching or domain displacement. Researchers from my postdoctoral training lab have shown that designed proteins can bind small molecules with sub-nanomolar affinity, designed enzymes can use a remote binding event to suppresses reactivity, and designed membrane proteins acting as part of a protein complex can transmit information from one binding event to influence distant kinase activity. Building from these recent advances in protein design, as well as the wealth of experimental data on signal transduction in helical bundle proteins such as G-protein coupled receptors and histidine kinases, the proposed research aims to develop new helical bundle proteins where binding of a ligand at one site increases the population of protein in a strained conformation, causing small molecule release at a second site. The capacity to design targeted proteins capable of small molecule delivery in response to changes in ligand concentration would give rise to powerful new capacities for biotechnology, and this proposal aims to explore release of two drugs for which de novo protein binders have been recently designed. In Aim 1, I will design a protein that releases the anti-cancer drug rucaparib upon binding of the pro-tumor metabolite itaconate. In Aim 2, I will design a protein that releases the anti-cancer drug apixaban following itaconate binding. Binding sites for the allosteric ligand and releasable molecule will be incorporated onto protein scaffolds built from stable helical bundles in combination with loops and kinks generated from diffusion-based probabilistic models. The resulting proteins will be expressed and purified, their binding will be assayed using fluorescence spectroscopy, and their structures will be determined using X-ray crystallography and NMR spectroscopy. Once successful allosterically regulated proteins are designed, new ligand binding sites will be positioned increasingly distal to the active site to explore progressively more remote strain transduction. Demonstrating intramolecular allosteric regulation within a single protein monomer will extend our understanding of a longstanding problem in protein biophysics. The proposed research project will advance my training goals as I integrate computational protein design, molecular biology and biochemistry techniques for cloning, protein expression and purification, and biophysical characterization. Combining my existing experience in physical chemistry with the skills developed during the proposed research will prepare me for an independent research career using proteins and synthetic macromolecules to understand and intervene in strained biological macromolecules.
Grant Summary
De novo design of allosterically regulated proteins to study intramolecular signal transduction is a NIGMS - National Institute of General Medical Sciences grant providing up to $75K for university, nonprofit, healthcare org. Applications are due 2028-02-29 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $75K
2028-02-29
- 1Confirm your organization is eligible for De novo design of allosterically regulated proteins to study intramolecular signal transduction from NIGMS - National Institute of General Medical Sciences, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIGMS - National Institute of General Medical Sciences before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NIGMS - National Institute of General Medical Sciences's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
De novo design of allosterically regulated proteins to study intramolecular signal transduction: Frequently Asked Questions
Who is eligible for the De novo design of allosterically regulated proteins to study intramolecular signal transduction?
De novo design of allosterically regulated proteins to study intramolecular signal transduction is offered by NIGMS - National Institute of General Medical Sciences and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the De novo design of allosterically regulated proteins to study intramolecular signal transduction provide?
De novo design of allosterically regulated proteins to study intramolecular signal transduction provides up to $75K per award from NIGMS - National Institute of General Medical Sciences. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the De novo design of allosterically regulated proteins to study intramolecular signal transduction deadline?
Applications for De novo design of allosterically regulated proteins to study intramolecular signal transduction are due 2028-02-29 (open). Because deadlines can change, verify the date with the funder, NIGMS - National Institute of General Medical Sciences, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the De novo design of allosterically regulated proteins to study intramolecular signal transduction?
To apply for De novo design of allosterically regulated proteins to study intramolecular signal transduction, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIGMS - National Institute of General Medical Sciences.